Skip to main content

Analysis of Filgrastim by Maurice

This protocol is intended as a guide only, for full experimental details please read the reference provided.

Summary

Filgrastim (commonly marketed as Neupogen®) is a commonly used drug used to treat white blood cell deficiencies.

EDQM catalogue number

Filgrastim: Y0001173, Batch 2

Maurice CE-SDS Method

Sample preparation: Filgrastim was diluted to 1.0 mg/mL with 1X Sample Buffer prior to treatment for 10 minutes at 70 °C in the presence of either 11.5 mM IAM (non-reduced) or 650 mM bME (reduced).

Running conditions: Samples were injected for 20 seconds at 4600 V, followed by a 35-minute separation at 5750 V.

Filgrastim Absorbance vs Relative Migration Time

Maurice icIEF method

Sample preparation: Filgrastim was diluted to 0.085 mg/mL.

Ampholyte solution: Pharmalytes 5–8 (4%) containing 8 M urea

Running conditions: 1 minute at 1500 V, 17 minutes at 3000 V

pI markers: 5.85 and 7.05

Imaging: Absorbance and fluorescence (3 seconds)

Filgrastim Fluorescence vs pI